AR059502A1 - USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR THE TREATMENT OF ADDICTION AND SUBSTANCE ABUSE - Google Patents

USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR THE TREATMENT OF ADDICTION AND SUBSTANCE ABUSE

Info

Publication number
AR059502A1
AR059502A1 ARP070100629A ARP070100629A AR059502A1 AR 059502 A1 AR059502 A1 AR 059502A1 AR P070100629 A ARP070100629 A AR P070100629A AR P070100629 A ARP070100629 A AR P070100629A AR 059502 A1 AR059502 A1 AR 059502A1
Authority
AR
Argentina
Prior art keywords
group
addiction
substance abuse
hydrogen
treatment
Prior art date
Application number
ARP070100629A
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR059502A1 publication Critical patent/AR059502A1/en

Links

Abstract

Método para el tratamiento de la adiccion y/o del abuso de sustancias que comprende administrar a un sujeto que lo necesita una cantidad terapéuticamente efectiva de uno o más nuevos derivados de benzo-heteroaril sulfamida de la formula (1) segun se definieron en la presente. Reivindicacion 1: Uso de un compuesto de la formula (1) en donde R1 está seleccionado del grupo que consiste en hidrogeno, halogeno, hidroxi, metoxi, trifluormetilo, nitro y ciano; X-Y está seleccionado del grupo que consiste en -S-CH-, -C(CH3)-, -OCH-, -O-C(CH3)-, -N(CH3)-CH- y -CH=CH-CH-; A está seleccionado del grupo que consiste en -CH2- y -CH(CH3)-; R2 está seleccionado del grupo que consiste en hidrogeno y metilo; R3 y R4 están cada uno independientemente seleccionados del grupo que consiste en hidrogeno y alquilo C1-4; alternativamente, R3 y R4 se toman conjuntamente con el átomo de nitrogeno al cual ellos están unidos para formar una estructura de anillo saturado, parcialmente no saturado o aromático de 5 a 7 miembros, que contiene opcionalmente uno a dos heteroátomos adicionales independientemente seleccionado del grupo que consiste en O, N y S; o una sal farmacéuticamente aceptable del mismo para la elaboracion de un medicamento para tratar la adiccion o el abuso de sustancias a un sujeto que lo necesita.Method for the treatment of addiction and / or substance abuse which comprises administering to a subject in need a therapeutically effective amount of one or more new benzo-heteroaryl sulfamide derivatives of the formula (1) as defined herein. . Claim 1: Use of a compound of the formula (1) wherein R1 is selected from the group consisting of hydrogen, halogen, hydroxy, methoxy, trifluoromethyl, nitro and cyano; X-Y is selected from the group consisting of -S-CH-, -C (CH3) -, -OCH-, -O-C (CH3) -, -N (CH3) -CH- and -CH = CH-CH-; A is selected from the group consisting of -CH2- and -CH (CH3) -; R2 is selected from the group consisting of hydrogen and methyl; R3 and R4 are each independently selected from the group consisting of hydrogen and C1-4 alkyl; alternatively, R3 and R4 are taken together with the nitrogen atom to which they are attached to form a saturated, partially unsaturated or aromatic ring structure of 5 to 7 members, optionally containing one to two additional heteroatoms independently selected from the group that consists of O, N and S; or a pharmaceutically acceptable salt thereof for the preparation of a medicament for treating addiction or substance abuse to a subject in need.

ARP070100629A 2006-02-15 2007-02-14 USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR THE TREATMENT OF ADDICTION AND SUBSTANCE ABUSE AR059502A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77372406P 2006-02-15 2006-02-15

Publications (1)

Publication Number Publication Date
AR059502A1 true AR059502A1 (en) 2008-04-09

Family

ID=38813278

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100629A AR059502A1 (en) 2006-02-15 2007-02-14 USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR THE TREATMENT OF ADDICTION AND SUBSTANCE ABUSE

Country Status (4)

Country Link
AR (1) AR059502A1 (en)
PE (1) PE20071306A1 (en)
TW (1) TW200808299A (en)
UY (1) UY30159A1 (en)

Also Published As

Publication number Publication date
PE20071306A1 (en) 2008-01-14
UY30159A1 (en) 2007-07-31
TW200808299A (en) 2008-02-16

Similar Documents

Publication Publication Date Title
AR059501A1 (en) USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR PAIN TREATMENT
AR050530A1 (en) DERIVATIVES OF HETEROARIL SULFAMIDA BENZO-FUSIONADA USEFUL AS ANTICONVULSIVE AGENTS
AR061066A1 (en) COTERAPEUTICS FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
AR054790A1 (en) METHODS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
EA200300354A1 (en) Quinoline derivatives as tyrosine kinase inhibitors
AR063602A1 (en) DERIVATIVES OF SPIROINDOLINONE, PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM AND THEIR USE IN THE OBTAINING OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL DISORDERS.
AR035482A1 (en) USE OF A CYANOQUINOLINE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OR INHIBIT COLONY POLYPS
UY29199A1 (en) TIAZOL DERIVATIVES, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS
AR047928A1 (en) TETRAHYDROPIRIDOINDOL DERIVATIVES
AR062886A1 (en) TIAZOL PIRAZOLOPIRIMIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT
AR054799A1 (en) OXINDOL DERIVATIVES
AR053364A1 (en) COMPOSITE OF 1H-IMIDAZO 84,5-C) PIRIDIN -2- ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCESS TO PREPARE IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT FOR TREATMENT OF CANCER OR ARTHRITIS
UY27503A1 (en) NEW DERIVATIVES OF PIPERAZINA
AR058389A1 (en) USE OF SULFAMIDE BENZO-FUSED HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF OBESITY
ECSP099394A (en) DERIVATIVES OF QUINUCLIDINOL AS ANTOGONISTS OF MUSCARINIC RECEPTORS
AR086100A1 (en) CHROMENONE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY29370A1 (en) DERIVATIVES OF TIAZOL, COMPOSITIONS THAT CONTAIN IT, PREPARATION PROCEDURES AND APPLICATIONS
UY31554A1 (en) NEW INHIBITORS OF ACETIL COENZIMA TO CARBOXYLASE AND USES IN OBESITY TREATMENTS AND MELLITUS DIABETES
AR072809A1 (en) COMPOSITE OF (3- PIRIDINILCARBONIL) -4- (PHENYLSULPHONYLPIPERAZINE), ITS USE FOR THE PREPARATION OF A MEDICINE FOR THE TREATMENT OF PAIN AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
AR029373A1 (en) METHOD FOR THE TREATMENT OF MIGRANES, USING SELECTIVE ANTAGONIST COMPOUNDS OF THE IGLUR5 RECEPTORS, USE OF SUCH SELECTIVE ANTAGONIST COMPOUNDS IN THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF MIGRANES AND SAVINGS COMPOSED
RU2013136895A (en) NEW BICYCLE COMPOUND OR ITS SALT
GEP20125548B (en) New dihidroindolone compounds, a process for its preparation and pharmaceutical compositions containing them
AR048573A1 (en) COMPOSITE OF 8-AZONIABICICLO [3.2.1] OCTANO REPLACED IN POSITION 3, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE THIS LAST
UY29739A1 (en) DERIVATIVES OF AMIDAS OR PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PROCESSES OF PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND APPLICATIONS
AR045914A1 (en) TERTIARY ALCOHOLIC COMPOUND OF 8-AZONIABICICLO [3.2.1] OCTOBER, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE THIS LAST

Legal Events

Date Code Title Description
FA Abandonment or withdrawal